IMM 3.08% 33.5¢ immutep limited

News: IMM Immutep Says FDA Approves Investigational New Drug Application For Eftilagimod Alpha, page-9

  1. 25,478 Posts.
    lightbulb Created with Sketch. 1388
    Marc Voight has made such an impressive effort in guiding a cash strapped company through trying times to
    get it to the stage where critical trial results are imminent....One wonders the direction Immutep may take
    if Marc manages to get funding behind him.....I'm sure Frederic will be licking his lips in anticipation...
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.